Cantitate/Preț
Produs

Clinical Manual of Geriatric Psychopharmacology

Autor Sandra A. Jacobson
en Limba Engleză Paperback – 15 apr 2014

As the baby boomer generation has begun to reach retirement age, the need for specialized knowledge on geriatric psychopharmacology has grown. Clinical Manual of Geriatric Psychopharmacology, Second Edition, serves a vital need for an expanding patient population, offering specialized information not available elsewhere in a standardized, well-organized format that clinicians will find easy to use. Extensively updated from the first edition to reflect the large body of new literature, this edition covers all newly available drugs, new safety warnings, information about adverse effects, and efficacy for expanded or more limited indications. Information is presented as concise bulleted text, and key concepts are highlighted in boxes. This edition is compatible with the new Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5(R)).

Understanding the complex pharmacological changes that occur with aging is critical for psychiatrists, psychiatric residents, and all health professionals who prescribe and/or monitor medications for geriatric patients. Clinical Manual of Geriatric Psychopharmacology, Second Edition, is comprehensive, current, and serves a critical need for the busy clinician.

Citește tot Restrânge

Preț: 59417 lei

Preț vechi: 62544 lei
-5% Nou

Puncte Express: 891

Preț estimativ în valută:
11371 11959$ 9472£

Carte disponibilă

Livrare economică 14-28 decembrie
Livrare express 30 noiembrie-06 decembrie pentru 3769 lei

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781585624546
ISBN-10: 1585624543
Pagini: 536
Ilustrații: black & white tables, tables, line drawings
Dimensiuni: 137 x 208 x 25 mm
Greutate: 0.54 kg
Ediția:2 Rev ed.
Editura: American Psychiatric Association Publishing

Notă biografică


Descriere

Clinical Manual of Geriatric Psychopharmacology, Second Edition, covers all newly available drugs, new safety warnings, information about adverse effects, and efficacy for expanded or more limited indications. Information is presented as concise bulleted text, and key concepts are highlighted. Consideration has been given to DSM-5 (R) compatibility.